Business Wire

Alipay Records Surge of China Inbound and Outbound Travel Spending During the 2025 Chinese New Year

5.2.2025 07:59:00 CET | Business Wire | Press release

Share

The number of Alipay transactions made by outbound Chinese travelers across the 90 million-strong Alipay+ global merchants network increased by 30% y-o-y. The top destinations for Chinese travelers are Singapore, Japan, Malaysia, Hong Kong SAR, and South Korea, showing the highest growth rate in total Alipay spending.China inbound travel spending via Alipay surged by 150% y-o-y in the first five days of the Chinese New Year (CNY) holiday. The number of inbound travelers using their 13 home e-wallets supported by the Alipay+ solution nearly doubled y-o-y during the first four days of the holiday.Alipay’s flagship Fortune Cards Campaign drew 600 million participants this year, reaching a cumulative of one billion users in the past decade since its launch in 2016.

During the 2025 Chinese New Year, Alipay recorded a significant increase in China’s outbound and inbound travel spending.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250204295908/en/

null

Shopping malls in Malaysia welcome Chinese tourists with special discounts on Alipay. (Photo: Business Wire)

Outbound travel: Visa-free and long-haul travel destinations saw a surge in Alipay spending while Chinese tourists sought local experiences

Through the Alipay+ cross-border mobile payment and digitalization solutions, Chinese travelers, along with users of the other 34 e-wallets in Asia and Europe, can use their own home payment app across 66 markets without the need to exchange currency or carry cash.

Global Alipay+ merchants have joined Alipay in an exclusive CNY campaign to lure travelers during the country's longest national holiday. From January 28th to 30th, the number of transactions made by Alipay users in overseas destinations increased by 30% compared to the same period last year.

Friendlier visa policies in major destinations bring substantive impact. In Singapore, total spending of Alipay rose by 56% year-on-year, making the Garden City the most popular destination. Japan also emerged as a favored spot, with a 40% increase in Alipay spending, driven by eased visa policies and a weakened yen. Malaysia, Hong Kong SAR, and South Korea also rank among the top five destinations.

Long-haul travel rebounded. Alipay users made 30% more transactions in Europe over CNY 2024. In addition to traditionally popular destinations like the UK, France, and Italy, emerging destinations such as Switzerland, Austria, and Turkey also saw a notable rise in number of transactions.

Thanks to Alipay+'s diverse global merchant network, Chinese tourists are increasingly seeking more personalized and local experience. Beyond shopping and entertainment, Alipay spending in cosmetic surgery rose by 449% year-on-year. Food spending via Alipay also shows a varied pattern, with spending on meals, snacks, and desserts increasing by 33%, 36%, and 54%, respectively. Greater interest in immersive local travel trends also drives local transportation usage. Total Alipay spending on overseas bus, subway and ride-hailing trips grew by 139% year-on-year.

Inbound travel: Visa-Free policies and new payment options drew international travelers to China to experience CNY traditions

With China’s recent visa-free policy updates, Alipay has launched new campaigns to double the number of Chinese merchants accepting payments with international card-enabled Alipay accounts and a total of 13 overseas e-wallets.

Through Alipay’s expanded partnerships with Visa, Mastercard, JCB, Discover®, Diners Club International®, and UnionPay International, travelers can link their international credit or debit card to their Alipay e-wallet for seamless payments and diverse digital services such as ride-hailing, hotel bookings, and purchasing plane and train tickets in China.

Between January 28th and February 1st, travelers spent 150% more using Alipay at merchants across the Chinese mainland over 2024. Spending from visa-free origins rose by 200% year-on-year.

Since September 2023, the Alipay+ solutions have supported 13 leading payment apps1 in Asia to serve their roaming users across Alipay’s 80-million-strong merchant network in China. During the first four days of the CNY holiday, the number of overseas e-wallet users making payments in China increased by 94% year-on-year. AlipayHK users topped the list, followed by Malaysia’s Touch ’n Go e-Wallet, Macao SAR’s MPay, Kazakhstan’s Kaspi.kz, and Thailand’s TrueMoney.

China native: New digital traditions drive consumer enthusiasm

In China, Alipay’s flagship Fortune Cards Campaign has become a new tradition for celebrating the Chinese New Year. Users collect digital fortune cards for good wishes and potential monetary rewards. With 28 sets of fortune cards—from Marvel heroes to Pop Mart stars—this year’s campaign has attracted 600 million participants. Utilizing technologies such as AR, AI, and Alipay Tap!, it continues to help merchants of all sizes—from street vendors to major brands—enhance consumer interactions. Now in its tenth year, the campaign has cumulatively reached over one billion users.

About Alipay

As the world becomes increasingly digital, Alipay has evolved from a trusted e-wallet into an all-in-one digital platform for daily services, connecting more than one billion consumers to over 80 million merchants across China. Alipay offers users a secure, seamless mobile payment experience and integrates over 10,000 services across sectors like travel, healthcare, tourism, and entertainment. With digital tools like Alipay Tap!, mini-programs, lifestyle accounts, Alipay enables merchants, institutions, and independent software vendors (ISVs) to enhance operational efficiency and effectiveness. In addition, Alipay is developing a new AI-driven open platform by integrating AI agents to deliver smarter, more personalized services to its users as well as facilitating the digital transformation of the service sector.

About Alipay+

Ant International’s Alipay+ is a suite of cross-border mobile payment and digitalisation solutions that help connect global merchants to consumers. Consumers enjoy seamless payment and a broad choice of deals using their preferred payment methods while travelling abroad. Small and medium-sized businesses may use Alipay+ digital tools to enhance efficiency and achieve omni-channel growth.

________________________
1
The 13 payment apps include AlipayHK (Hong Kong SAR, China), Kaspi.kz (Kazakhstan), MPay (Macao SAR, China), Touch ’n Go eWallet (Malaysia), Hipay (Mongolia), NayaPay (Pakistan), Changi Pay (Singapore), OCBC Digital (Singapore), Kakao Pay (South Korea), Naver Pay (South Korea), Toss Pay (South Korea), TrueMoney (Thailand), GCash (The Philippines).

View source version on businesswire.com: https://www.businesswire.com/news/home/20250204295908/en/

null
null

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Kubota Vision Inc. Signs Supply and Licensing Agreement with Laboratoires KÔL for Stargardt Disease Treatment Candidate Under Compassionate Use4.5.2026 17:16:00 CEST | Press release

Kubota Vision Inc. (“Kubota Vision”), a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Minato-ku, Tokyo, Japan) announced signing of a Supply and Licensing Agreement with Laboratoires KÔL (Clermont-Ferrand, France) for the provision of a Stargardt disease (STGD1) treatment candidate under compassionate use authorization. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260414590785/en/ The purpose of this Agreement is for Kubota Vision and KÔL to collaborate on providing “Emixustat” for treatment of Stargardt Disease (STGD1) through compassionate use authorization in France. Kubota Vision will exclusively manufacture and supply Emixustat final products to KÔL and KÔL will have exclusive rights to distribute Emixustat in France under compassionate use access. Ryo Kubota, Chairman, President, and CEO of Kubota Pharmaceutical Holdings, stated, “We are extremely pleased to enter into this Agreement with Labor

Incentive Market Set to Surpass $80B by 2030s — IMA Launches Tools to Help the Industry Keep Pace4.5.2026 16:28:00 CEST | Press release

With combined business spend on loyalty, employee recognition, and channel incentives projected to exceed $80 billion by the 2030s, the incentive industry is entering a period of rapid scale and strategic pressure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260422729016/en/ In response, the Incentive Marketing Association (IMA) launched a new suite of resources designed to help incentive professionals navigate an environment that’s becoming more specialized, fragmented, and central to business performance. “It’s not just more money coming in—it’s more complexity,” said Vince Chiofolo, President of the Incentive & Engagement Solution Providers (IESP). “Buyers are demanding programs that evolve fast, integrate deeply, and feel personal at scale. These new tools were built for that.” IMA’s Suite of Tools Includes: New Industry Report — Inside the Incentive Buyer’s Mind Drawn from insights of 50+ program owners, the report f

Tigo Energy Breaks Global Growth Benchmark; Boosts U.S. Energy Feature in Predict+4.5.2026 15:00:00 CEST | Press release

Advanced energy prediction platform adds real-time energy pricing for North American Independent System Operator (ISO) customers, accelerates meters-connected growth. Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo” or “Company”), a leading provider of intelligent solar and energy solutions, today announced that the Predict+ platform now offers integrated real-time spot market pricing for ISO customers in the United States. Predict+ provides utilities with deep insights into grid demand, renewable generation, and energy market dynamics, enhancing the precision, scalability, and robustness of energy forecasting to up to 97.5% accuracy through machine learning and artificial intelligence. For energy providers, Predict+ helps streamline operations, reduce volatility, and maximize performance. Predict+ empowers utility operators to adapt to real-world demand challenges when balancing renewable and baseload generation sources, particularly during extreme weather events and market disruptions. On th

Airship Announces 2026 Elevate Customer Experience Award Winners4.5.2026 15:00:00 CEST | Press release

Southwest Airlines, The Economist, and OneFootball among brands recognized at Elevate’26 Customer Experience Summit for setting the standard in mobile-first and AI-centered customer experiences Airship, the mobile-first customer experience company, today announced the winners of the 2026 Elevate Customer Experience Awards. Global brand leaders from The Economist, Southwest Airlines, and OneFootball were among those honored at the Elevate’26 Customer Experience Summit. The Elevate Awards spotlight global companies that have developed exceptional mobile-first customer experiences for their customers, created innovative campaigns, leveraged AI agents to reach new levels of productivity, and achieved real business results. "Evolving mobile-first consumer behaviors and unprecedented advancements in AI are driving a seismic shift that is reshaping how brands interact with their customers," said Brett Caine, CEO, Airship. "The 2026 Elevate Award winners aren’t just adapting, they’re leading t

Alnylam to Present New Analyses at Heart Failure 2026 Underscoring Consistent Clinical Profile of Vutrisiran in ATTR-CM4.5.2026 14:30:00 CEST | Press release

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced it will present new data analyses for vutrisiran in patients with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) at Heart Failure 2026, a scientific congress of the European Society of Cardiology, taking place May 9-12, 2026, in Barcelona, Spain. ATTR-CM is a heterogeneous and rapidly progressive disease, and patients often present with complex clinical profiles. At Heart Failure 2026, Alnylam will present multiple new analyses from the Phase 3 HELIOS-B study of vutrisiran, which continue to support its use as a first-line treatment for patients with ATTR-CM, and further characterize its clinical profile across patients with a high disease burden, and in the context of concomitant therapies. Vutrisiran is the first and only transthyretin (TTR) silencer for ATTR-CM that delivers rapid knockdown of TTR at the source. Additional analyses being pr

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye